To inform the ongoing implementation of a tele-trial model, feedback is sought from sponsors that have experience in implementing tele-trials in Australia or are actively considering utilising tele-trials.
Information gathered will be used to identify the barriers and enablers for tele-trials within Australia, inform the ongoing implementation of a tele-trial model, and for the final report for the Clinical Oncology Society of Australia (COSA)/Medicines Australia Tele-Trials Project.
If you have implemented a tele-trial within your company, the survey will take approximately 20 minutes to complete. Take the survey now.
If you have not implemented a tele-trial within your company but are actively considering implementing or are intending to implement a tele-trial, the survey will take approximately 10 minutes to complete. Take the survey now.
Please complete the survey by 28 September 2020.
The model has been developed in consultation with clinical trial sponsors, clinicians, health administrators and regulatory bodies.
Medicines Australia said, “While the model was initially designed to increase access to clinical trials for people with cancer living in rural and remote locations, it became apparent that the model was applicable for all clinical trials. This has become particularly significant and achievable through the rapid uptake of telehealth, which will further facilitate clinical trial activity across rural and remote locations.
“Developed and piloted over three years, the COSA tele-trials project has demonstrated its proof of concept, including that it can be scaled up nationally for all tele-trials. There are already many patients participating in tele-trials across Australia, including in Queensland, NSW, ACT, Victoria and South Australia.”